Neurocrine Biosciences (NBIX) Earnings Call Transcripts

Price: $103.395
Market Cap: $10.23B
Avg Volume: 1.56M
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 0.334
52W Range: $84.23-157.98
Website: Neurocrine Biosciences
Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-02-06 $1.62 $1.00
Read Transcript Q3 2024 2024-10-30 $1.51 $1.24
Read Transcript Q2 2024 2024-08-01 $1.05 $0.63
Read Transcript Q1 2024 2024-05-01 $1.01 $0.42
Read Transcript Q4 2023 2024-02-07 $1.15 $1.44
Read Transcript Q3 2023 2023-10-31 $0.97 $0.82
Read Transcript Q2 2023 2023-08-01 $0.78 $0.95
Read Transcript Q1 2023 2023-05-03 $0.26 $-0.79
Read Transcript Q4 2022 2023-02-06 $1.16 $0.88
Read Transcript Q3 2022 2022-11-01 $0.79 $0.69
Read Transcript Q2 2022 2022-08-04 $0.56 $-0.18
Read Transcript Q1 2022 2022-05-04 $0.35 $0.14
Read Transcript Q4 2021 2022-02-11 $0.61 $-0.08
Read Transcript Q3 2021 2021-11-01 $0.51 $0.23
Read Transcript Q2 2021 2021-08-03 $0.48 $0.43
Read Transcript Q1 2021 2021-05-05 $0.51 $0.33
Read Transcript Q4 2020 2021-02-04 $0.59 $3.58
Read Transcript Q3 2020 2020-11-10 N/A N/A
Read Transcript Q2 2020 2020-08-03 $0.73 $0.81
Read Transcript Q1 2020 2020-05-07 N/A N/A
Read Transcript Q4 2019 2020-02-04 $0.75 $0.35
Read Transcript Q3 2019 2019-11-05 N/A N/A
Read Transcript Q2 2019 2019-07-29 $0.24 $0.37
Read Transcript Q1 2019 2019-04-29 $-1.05 $-1.12
Read Transcript Q4 2018 2019-02-05 $0.18 $0.19
Read Transcript Q3 2018 2018-11-05 $0.46 $0.52
Read Transcript Q2 2018 2018-07-31 $-0.18 $-0.07
Read Transcript Q1 2018 2018-04-30 $-0.32 $-0.47
Read Transcript Q4 2017 2018-02-13 $0.18 $0.07
Read Transcript Q3 2017 2017-11-02 N/A N/A
Read Transcript Q2 2017 2017-08-04 N/A N/A
Read Transcript Q1 2017 2017-05-14 N/A N/A
Read Transcript Q4 2016 2017-02-14 $-0.55 $-0.51
Read Transcript Q3 2016 2016-11-03 N/A N/A
Read Transcript Q2 2016 2016-08-03 $-0.50 $-0.46
Read Transcript Q1 2016 2016-05-05 $-0.28 $-0.22

Related Metrics

Explore detailed financial metrics and analysis for NBIX.